1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- manufacturers
- GLP-1R agonist 9
-
- $2580.00
-
2026-07-27
- CAS:2401894-00-4
- Purity:
- Supply Ability: 10g
|
| | 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- Basic information |
| | 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- Chemical Properties |
| Boiling point | 735.4±60.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 7.58±0.10(Predicted) |
| | 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- Usage And Synthesis |
| Uses | GLP-1R agonist 9 (Compound 96) is a GLP-1R agonist with EC50 values of 1.1 nM and 11 nM against CHO GLP-1R Clone H6 and CHO GLP-1R Clone C6, respectively[1]. | | References | [1] Gary E. Aspnes, et al. Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases. WO2020234726A1. |
| | 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-chloro-2-fluorophenyl)-7-fluoro-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- Preparation Products And Raw materials |
|